GSK's RAPT Therapeutics acquisition will strengthen the former's immunology pipeline – specifically its offerings for food ...

Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the ...

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

André Cerbe, CEO of Schlafender Hase, spoke with Pharmaceutical Technology® about the disruptions the pharma industry faced in 2025 and how digital workflows will be key for success in 2026. After a ...

NANJING, China--(BUSINESS WIRE)--Triastek Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals, today announced that it has entered into a research collaboration and platform technology ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

The global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast period. This positive outlook is fueled by rising global ...

Henan Medinno Pharmaceutical Technology Co. Ltd. has synthesized TGF-β receptor type-1 (TGFBR1; ALK5; SKR4; TβR-I) inhibitors reported to be useful for the treatment of cancer, aging, arteriosclerosis ...

@2024 - All Right Reserved.

Beijing Danatlas Pharmaceutical Technology Co. Ltd. has identified thiadiazolyl derivatives acting as DNA polymerase θ (POLθ, POLQ) inhibitors reported to be useful for the treatment of cancer.

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...